619 related articles for article (PubMed ID: 23528241)
1. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
[TBL] [Abstract][Full Text] [Related]
3. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification.
Zauner L; Melroe GT; Sigrist JA; Rechsteiner MP; Dorner M; Arnold M; Berger C; Bernasconi M; Schaefer BW; Speck RF; Nadal D
Oncogene; 2010 Aug; 29(32):4588-98. PubMed ID: 20514021
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
7. Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.
Gerle B; Koroknai A; Fejer G; Bakos A; Banati F; Szenthe K; Wolf H; Niller HH; Minarovits J; Salamon D
J Virol; 2007 Dec; 81(23):13242-7. PubMed ID: 17898065
[TBL] [Abstract][Full Text] [Related]
8. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
[TBL] [Abstract][Full Text] [Related]
10. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.
Fejer G; Koroknai A; Banati F; Györy I; Salamon D; Wolf H; Niller HH; Minarovits J
J Gen Virol; 2008 Jun; 89(Pt 6):1364-1370. PubMed ID: 18474551
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Niller HH; Wolf H; Minarovits J
Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
[TBL] [Abstract][Full Text] [Related]
12. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
13. The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.
Szenthe K; Koroknai A; Banati F; Bathori Z; Niller HH; Wolf H; Nagy N; Klein E; Minarovits J; Salamon D
Biochem Biophys Res Commun; 2013 May; 435(1):8-15. PubMed ID: 23583387
[TBL] [Abstract][Full Text] [Related]
14. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
15. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.
Larsson L; Thorbert-Mros S; Rymo L; Berglundh T
Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916
[TBL] [Abstract][Full Text] [Related]
16. Role of epigenetics in EBV regulation and pathogenesis.
Niller HH; Tarnai Z; Decsi G; Zsedényi A; Bánáti F; Minarovits J
Future Microbiol; 2014; 9(6):747-56. PubMed ID: 25046522
[TBL] [Abstract][Full Text] [Related]
17. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
19. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.
Li H; Minarovits J
Adv Cancer Res; 2003; 89():133-56. PubMed ID: 14587872
[TBL] [Abstract][Full Text] [Related]
20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
